ALLO news

Allogene Therapeutics increased total authorized shares from previous levels to 810 million, comprising 800 million common shares and 10 million preferred shares. The amendment, approved by shareholders and effective June 18, 2026, provides additional capital structure flexibility for future financi…

Allbirds, Inc. amended its certificate of incorporation to change its corporate name to Smartbird, Inc., effective June 15, 2026. The filing also revised the company's business purposes clause and reserved a provision in its charter.